title: Levomepromazine for nausea and vomiting in advanced cancer.
abstract: Levomepromazine (previously known as methotrimeprazine), despite virtually no high quality scientific data to support its use, has become a very popular antiemetic for use in patients with advanced cancer. This article considers the reasons for this.
authors.affiliation: Liverpool Marie Curie Centre.
authors.forename: J
authors.initials: J
authors.lastname: Skinner
authors.forename: A
authors.initials: A
authors.lastname: Skinner
mesh_terms: D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008728:Methotrimeprazine / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology
chemical_list: D018492:Dopamine Antagonists; D008728:Methotrimeprazine